Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind placebo-controlled phase III trial of Antaiwei granules for common cold (wind-cold pattern)
CTR20233850Phase 3Completed
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Nov 2023
- Countries
- 1
01
Overview
A Phase 3 trial of Antaiwei granules in nasopharyngitis, sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Nov 2023; status: completed.
02
Drugs
Antaiwei granules
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20233850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233850.